Sun, Apr 20, 2014, 12:33 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

PetSmart, Inc. Message Board

driscoj 3 posts  |  Last Activity: Mar 5, 2014 7:59 AM Member since: Jan 31, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • This functional validation should be completed any week now. Look for good news, then a push higher.

    Early spring 2014
    At the risk of making a complex subject sound simple, the company has created liver cells that behave like the liver cells in our bodies for up to 30 days. That's a vast improvement over what is available now for pharmaceutical companies looking to see if their drugs are toxic to the liver.

    Just this month, the company began functional validation of these 3-D liver assays. Basically, this means that the assays will be exposed to drugs whose effect on real liver tissue is known. In order for Organovo's assays to have any value, they need to demonstrate the same metabolic reactions that occur in the body. Hopefully, investors will know by sometime in March whether the assays produced the desired results.

    Sentiment: Buy

  • Earnings out on Monday. Oxecta sales must be picking up AND additional new pharmacies could pick up Nexafed soon. This stock is heading for 3.............

    Sentiment: Buy

  • Reply to


    by livindalifeaquatic Jan 21, 2014 6:31 PM
    driscoj driscoj Jan 21, 2014 8:01 PM Flag

    You think the NIH (Gov'T) would sign on to collaborate with a "fraud" company? These people know this stock could sky rocket, and they are trying to knock it down

    Sentiment: Strong Buy

66.80-0.11(-0.16%)Apr 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.